Perrigo Co has been granted a patent for a nutritional composition, particularly for infants, containing milk fat globule membrane, human milk oligosaccharide, and components like DHA, ARA, Vitamin E, Vitamin C, and sphingomyelin. The composition aims to provide essential nutrients for infant development. GlobalData’s report on Perrigo Co gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData


Premium Insights Perrigo Co Plc - Company Profile

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Perrigo Co, was a key innovation area identified from patents. Perrigo Co's grant share as of February 2024 was 43%. Grant share is based on the ratio of number of grants to total number of patents.

Infant nutritional composition with specific components

Source: United States Patent and Trademark Office (USPTO). Credit: Perrigo Co Plc

The granted patent (Publication Number: US11849747B1) discloses a nutritional composition that includes a milk fat globule membrane component derived from whey protein sources in dry powder form. This component has a protein content of at least 60% by weight and a lactose content of not more than 5% by weight. The composition also contains at least one human milk oligosaccharide, such as 2'FL, and additional components like DHA, ARA, Vitamin E, Vitamin C, and sphingomyelin.

Furthermore, the nutritional composition may include various human milk oligosaccharides like fucosyllactose, 3FL, LNFP I, LNFP II, LNFP V, and mixtures thereof. These oligosaccharides are present in the composition in specific amounts per reconstituted liter. The patent claims that the combination of human milk oligosaccharides, milk fat globule membrane, and DHA in the composition provides synergistically enhanced amounts of DHA in the phospholipid form. The composition is intended for use as an infant formula, with specific amounts of DHA ranging from 37 mg to 180 mg per reconstituted liter, suitable for term infants or as a human milk fortifier.

To know more about GlobalData’s detailed insights on Perrigo Co, buy the report here.

Premium Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies